bortezomib will increase the level or impact of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Improved flibanserin adverse outcomes may well come about if coadministered with various weak CYP3A4 inhibitors.Unlock 38% additional drug discovery time and eradicate choice-earning doubts using this typ